Skip to content
Disclosery

ABG-WTT Global Life Science Capital Partners GP Ltd

Follow

13F filer, CIK 1832108, CENTRAL, HONG KONG, Hong Kong

ABG-WTT Global Life Science Capital Partners GP Ltd reported $12,294,193 across 2 holdings for the quarter ended 2026-03-31, in a 13F-HR filed 2026-05-18.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001193125-26-227557

Period
2026-03-31
Reported value
$12.3M
Holdings
2
Top 10 weight
100%
New
0
Sold out
0

Holdings, Q1 2026

Share positions as resolved from 13F-HR 0001193125-26-227557, largest first. % of portfolio is the value over $12,294,193, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
CBLLCERIBELL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 1,088,101 shares; 2025Q1: 1,088,101 shares; 2025Q2: 1,088,101 shares; 2025Q3: 1,088,101 shares; 2025Q4: 441,820 shares; 2026Q1: 441,820 shares 441,820$8.1M65.87%0Timeline
RPIDRAPID MICRO BIOSYSTEMS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,038,296 shares; 2024Q4: 1,038,296 shares; 2025Q1: 1,848,296 shares; 2025Q2: 1,848,296 shares; 2025Q3: 1,848,296 shares; 2025Q4: 1,848,296 shares; 2026Q1: 1,848,296 shares 1,848,296$4.2M34.13%0Timeline

How Q1 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001193125-26-227557 base2026-05-18acceptance time not in the bulk data set